Veterinary Pain Management Market By Product Type (Drugs, Devices), By Application (Degenerative diseases, Post-surgical orthopedic complexities, Neurologic impairments, Chronic musculoskeletal laxity, Dermatologic diseases, Postchemotherapy gastrointestinal disease) - Growth, Future Prospects and Competitive Analysis 2018-2026

Veterinary pain management market accounted for a market value of US$ 1,078.5 Mn in 2017 and projected to grow at a CAGR of 7.9% during the forecast period from 2018 to 2026. Rising humanization of animals due to developing trend of nuclear family, continuous development in the research & development activities related to the veterinary pain management, and scheduled diagnostics sessions for livestock to maintain the quality of the meat, milk and other products. Improper feeding and unorganized health management of pets & livestock animals leads to obesity and finally leading to joint pain and other disorders. In addition to that, pet and livestock owners are also being counselled & trained by non-government organizations or veterinary doctors to manage health of animals.

Market Synopsis

Get a sample copy for more information

"Drugs are preferred for its instant and target specific therapeutic effect to manage pain in pets & livestock"

The drugs preferred in pain management are opioids, α2-adrenergic agonists, non-steroidal anti-inflammatory drugs, disease-modifying anti-rheumatic drugs, and others including sedatives and corticosteroids. Thus, the choice of drug based on the type of disease and intensity of pain. Drugs have been and will always remain primary choice for pain management in veterinary. The key factors responsible for growth of drugs segment are rising prevalence of pain-inducing disorders, increasing advancements in clinical trials for veterinary pain management, and  wide range of drug options provide flexibility to veterinary doctor to manage pain management.

Get a sample copy for more information

"Increasing humanization of pets, and rising awareness related to diagnosis & treatment of livestock in Asian countries will drive the market for veterinary pain management"

Asia Pacific expected to grow significantly throughout the forecast period from 2018 to 2026, the major market drivers assisting its growth are rising prevalence of degenerative diseases in Asia, rising awareness related to diagnosis & treatment of diseases affecting pets & livestock, and rising adoption & humanization of pets trending in Asian countries. According to industry experts, every year in India around 600,000 pets (as of 2016) adopted and the rising population of pets has open several opportunities for occupations & businesses related to pet healthcare in the country. According to the National Bureau of Statistics of China, in 2014 China had 27.4 million pet dogs and 58.1 million pet cats. Thus, Indian & China observed as the most promising and potential veterinary pain management markets in the near future.

Get a sample copy for more information

Historical & Forecast Period

The veterinary pain management market analyzed considering current market trends for base year 2017 and based on future trends CAGRs calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

This report provides in-depth analysis related to veterinary pain management market including market interpretations and conclusions presented based on qualitative and quantitative data extracted through secondary and primary research. Industry experts have helped to analyze and derive market drivers, opportunities & challenges further narrowed down to region-level & country-level. This report also covers detailed analysis of global veterinary pain management market segmented as types of product, application, and geography. The report also provides competitive analysis of the key players present in veterinary pain management market that covers in-depth data related to the companies along with latest business strategies & product profiles.

The major companies present in the market profiled based on product portfolio, latest market updates, financial information, and key strategies. This report also covers attractive investment proposition analyzed with the assistance of comprehensive geographical research based on PESTEL analysis. Key companies analyzed in the report are Zoetis, Chanelle Veterinary Limited, Assisi Animal Health, Boehringer Ingelheim, Merck Animal Health, Vetoquinol, Norbrook, Elanco, Ceva Santé Animale, Bayer, K-Laser, and Dechra Pharmaceuticals among others.

Key questions answered in this report

• Which is the trending product type in the market preferred for veterinary pain management & Why?
• What are the recent market strategies applied by key players & competitive analysis specific to veterinary pain management market?
• Which are the major geographical markets (regions and countries) in veterinary pain management market?
• Which is the largest and fastest growing intracranial stent types globally?
• How is the competitive landscape of veterinary pain management market and policies of major players present in this industry?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global VPM Market Portraiture
2.2. Global VPM Market, by Type of Product, 2017 (US$ Mn)
2.3. Global VPM Market, by Type of Application, 2017 (US$ Mn
2.4. Global VPM Market, by Geography, 2017 Vs 2026 (Value %)

Chapter 3. Global Veterinary Pain Management (VPM) Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.2.1. Increasing prevalence of degenerative diseases in pets & farm animals
3.2.2. Rising awareness related to the diagnosis & treatment of pain-inducing diseases & conditions
3.3. Challenges
3.3.1. Lack of early diagnosis & minimum penetration in rural & remote parts of South America, Asia & Africa
3.4. Opportunities
3.4.1. Ongoing technological advancements in the field of veterinary diagnosis & treatment expected to assist the growth & penetration of VPM market
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2017

Chapter 4. Global Veterinary Pain Management (VPM) Market, by Type of Product, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Drugs
4.2.1. Opioids
4.2.2. α2-adrenergic Agonists
4.2.3. Local Anesthetics
4.2.4. Nonsteroidal Anti-inflammatory Drugs (NSIDs)
4.2.5. Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
4.2.6. Others (Sedatives, Corticosteroids etc.)
4.3. Devices
4.3.1. Laser Therapy
4.3.2. Electromagnetic Therapy

Chapter 5. Global Veterinary Pain Management (VPM) Market, by Type of Application, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. Degenerative diseases (e.g., osteoarthritis, Cushing’s disease)
5.3. Post-surgical orthopedic complexities
5.4. Neurologic impairments
5.5. Chronic musculoskeletal laxity
5.6. Dermatologic diseases
5.7. Postchemotherapy gastrointestinal disease

Chapter 6. Global Veterinary Pain Management (VPM) Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. Overview
6.2. North America VPM Market Analysis, 2016 – 2026
6.2.1. North America VPM Market, by Type of Product, 2016–2026 (US$ Mn)
6.2.2. North America VPM Market, by Type of Application, 2016–2026 (US$ Mn)
6.2.3. North America VPM Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe VPM Market Analysis, 2016 – 2026
6.3.1. Europe VPM Market, by Type of Product, 2016–2026 (US$ Mn)
6.3.2. Europe VPM Market, by Type of Application, 2016–2026 (US$ Mn)
6.3.3. Europe VPM Market, by Country, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific VPM Market Analysis, 2016 – 2026
6.4.1. Asia Pacific VPM Market, by Type of Product, 2016–2026 (US$ Mn)
6.4.2. Asia Pacific VPM Market, by Type of Application, 2016–2026 (US$ Mn)
6.4.3. Asia Pacific VPM Market, by Country, 2016 – 2026 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. Rest of APAC
6.5. Latin America VPM Market Analysis, 2016 – 2026
6.5.1. Latin America VPM Market, by Type of Product, 2016–2026 (US$ Mn)
6.5.2. Latin America VPM Market, by Type of Application, 2016–2026 (US$ Mn)
6.5.3. Latin America VPM Market, by Country, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) VPM Market Analysis, 2016 – 2026
6.6.1. Middle East & Africa VPM Market, by Type of Product, 2016–2026 (US$ Mn)
6.6.2. Middle East & Africa VPM Market, by Type of Application, 2016–2026 (US$ Mn)
6.6.3. MEA VPM Market, by Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Boehringer Ingelheim
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Zoetis
7.3. Elanco
7.4. Merck Animal Health
7.5. Bayer
7.6. Vetoquinol
7.7. Norbrook Laboratories
7.8. Ceva Santé Animale
7.9. Dechra Pharmaceuticals
7.10. Chanelle
7.11. K-Laser USA
7.12. Assisi Animal Health

* VPM - Veterinary Pain Management

FIG. 1 Veterinary Pain Management (VPM): Market Segmentation
FIG. 2 Global VPM Market Share, by Type of Product, 2017 (US$ Mn)
FIG. 3 Global VPM Market Share, by Type of Application, 2017 (US$ Mn)
FIG. 4 Global VPM Market, by Geography, 2017 Vs 2026 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography, 2017
FIG. 6 Market Competition Landscape, by Key Players, 2017
FIG. 7 Global Opioids Market for VPM, 2016 – 2026 (US$ Mn)
FIG. 8 Global α2-adrenergic Agonists Market for VPM, 2016 – 2026 (US$ Mn)
FIG. 9 Global Local Anesthetics Market for VPM, 2016 – 2026 (US$ Mn)
FIG. 10 Global Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for VPM Market, 2016 – 2026 (US$ Mn)
FIG. 11 Global Disease-Modifying Anti-Rheumatic Drugs (DMARDs) for VPM Market, 2016 – 2026 (US$ Mn)
FIG. 12 Global Other Drugs Market for VPM, 2016 – 2026 (US$ Mn)
FIG. 13 Global Laser Therapy Devices Market for VPM, 2016 – 2026 (US$ Mn)
FIG. 14 Global Electromagnetic Therapy Devices Market for VPM, 2016 – 2026 (US$ Mn)
FIG. 15 Global VPM Market for Degenerative Diseases, 2016 – 2026 (US$ Mn)
FIG. 16 Global VPM Market for Post-surgical Orthopedic Complexities, 2016 – 2026 (US$ Mn)
FIG. 17 Global VPM Market for Neurologic Impairments, 2016 – 2026 (US$ Mn)
FIG. 18 Global VPM Market for Chronic Musculoskeletal Laxity, 2016 – 2026 (US$ Mn)
FIG. 19 Global VPM Market for Dermatologic Diseases, 2016 – 2026 (US$ Mn)
FIG. 20 Global VPM Market for Post-chemotherapy Gastrointestinal Disease, 2016 – 2026 (US$ Mn)
FIG. 21 U.S. VPM Market, 2016 – 2026 (US$ Mn)
FIG. 22 Canada VPM Market, 2016 – 2026 (US$ Mn)
FIG. 23 U.K. VPM Market, 2016 – 2026 (US$ Mn)
FIG. 24 Germany VPM Market, 2016 – 2026 (US$ Mn)
FIG. 25 Rest Of Europe VPM Market, 2016 – 2026 (US$ Mn)
FIG. 26 Japan VPM Market, 2016 – 2026 (US$ Mn)
FIG. 27 China VPM Market, 2016 – 2026 (US$ Mn)
FIG. 28 Rest Of Asia Pacific VPM Market, 2016 – 2026 (US$ Mn)
FIG. 29 Brazil VPM Market, 2016 – 2026 (US$ Mn)
FIG. 30 Mexico VPM Market, 2016 – 2026 (US$ Mn)
FIG. 31 Rest Of Latin America VPM Market, 2016 – 2026 (US$ Mn)
FIG. 32 GCC VPM Market, 2016 – 2026 (US$ Mn)
FIG. 33 Rest Of Middle East And Africa VPM Market, 2016 – 2026 (US$ Mn)

TABLE 1 Global Veterinary Pain Management (VPM) Market, by Type of Product, 2016 – 2026 (US$ Mn)
TABLE 2 Global VPM Market, by Type of Application, 2016 – 2026 (US$ Mn)
TABLE 3 North America VPM Market, by Type of Product, 2016 – 2026 (US$ Mn)
TABLE 4 North America VPM Market, by Type of Application, 2016 – 2026 (US$ Mn)
TABLE 5 North America VPM Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 6 Europe VPM Market, by Type of Product, 2016 – 2026 (US$ Mn)
TABLE 7 Europe VPM Market, by Type of Application, 2016 – 2026 (US$ Mn)
TABLE 8 Europe VPM Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 9 Asia Pacific VPM Market, by Type of Product, 2016 – 2026 (US$ Mn)
TABLE 10 Asia Pacific VPM Market, by Type of Application, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific VPM Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 12 Latin America VPM Market, by Type of Product, 2016 – 2026 (US$ Mn)
TABLE 13 Latin America VPM Market, by Type of Application, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America VPM Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 15 Middle East & Africa VPM Market, by Type of Product, 2016 – 2026 (US$ Mn)
TABLE 16 Middle East & Africa VPM Market, by Type of Application, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East And Africa VPM Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 18 Boehringer Ingelheim: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 19 Zoetis: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 Elanco: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 Merck Animal Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 Bayer: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Vetoquinol: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Norbrook Laboratories : Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 Ceva Santé Animale: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Dechra Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Chanelle: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 K-Laser USA: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Assisi Animal Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)